Umeclidinium/vilanterol compared with fluticasone propionate/salmeterol, budesonide/ formoterol, and tiotropium as initial maintenance therapy in patients with copd who have high costs and comorbidities

Ravi Kalhan, David Slade, Riju Ray, Chad Moretz, Guillaume Germain, François Laliberté, Qin Shen, Mei Sheng Duh, Sean Dale Macknight, Beth Hahn*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Umeclidinium/vilanterol compared with fluticasone propionate/salmeterol, budesonide/ formoterol, and tiotropium as initial maintenance therapy in patients with copd who have high costs and comorbidities'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences